Australia's home of IPO investment
Providing you with fair, fast and easy access to more IPOs than anywhere else
198
Successful Raisings
$150.7M
Capital Raised
62,761
OnMarket Crowd
Discover IPO investment opportunities here
See performance of OnMarket IPOs and Placements here
Revolver Resources Holdings Ltd ASX: RRR
The Revolver Resources Holdings Ltd IPO has successfully closed. The Company is currently progressing with the required ASX listing approvals, and the allotment and ASX listing dates will be advised soon.
X2M Connect Ltd ASX: X2M
The X2M Connect Ltd IPO has successfully closed. Allotment of shares is expected to occur on Monday, 13 September, and the planned ASX listing date is Friday, 17 September (subject to confirmation by ASX).
Zoom2u Technologies Ltd ASX: Z2U
The Zoom2u Ltd IPO has successfully closed. Allotment of shares has occured and the Company will list on ASX on Friday, 10 September at 11am AEST.
Way 2 Vat Ltd ASX: W2V
The Way 2 Vat Ltd IPO has successfully closed. The shares have been allotted, and the Company is expecting to list on ASX at 1pm, Friday 17th September.
Koonenberry Gold Ltd ASX: KNB
The Koonenberry Gold IPO has successfully closed and the company will list on the ASX shortly.
TEK-Ocean Group Ltd ASX: T3K
The TEK-Ocean Group Ltd IPO has successfully closed. Allotment of shares has occurred and the ASX listing has been confirmed at 11am on Thursday 2nd September.
Culpeo Minerals Ltd ASX: CPO
The Culpeo Minerals Limited (ASX: CPO) has successfully closed. The shares have been allotted, and the ASX listing date has been confirmed as 1:30pm on Friday 10 Septmeber.
Pantera Minerals Ltd ASX: PFE
Pantera Minerals Limited (ASX: PFE) is an Australian resources company focused on the exploration of its Yampi iron ore project, its Weelaranna manganese project and its Frederick polymetallic project all located in Western Australia
BCAL Diagnostics Ltd ASX: BDX
BCAL Diagnostics Ltd (ASX: BDX) is developing a new diagnostic approach for breast cancer using an in vitro diagnostic (IVD) blood test. BCAL’s initial focus is to achieve Australian regulatory approval for its breast cancer diagnostic product to be employed alongside traditional mammography.
Fair, easy access to IPOs
Gain access
Now everyone can invest in IPOs. Get ASX IPOs delivered to your inbox. It’s never been easier to get fair, free access to IPOs.
Informed investing
View free digestible, relevant, research and video interviews with company management before deciding what to invest in.
Easy bidding process
Fast, simple, secure bidding into IPOs either via the OnMarket app or website. Buy shares directly from your phone.
Performance of OnMarket IPOs and Placements
OnMarket 2020 IPO Report available here. ASX IPOs in 2020 returned an average of 46.9% for 2020, outperforming the ASX200 by 48%
*Based on both open and closed positions of the 163 listed offers as at 1 September 2021.
Performance figures are calculated using a simple average method.
See comprehensive breakdown and calculation of returns
OnMarket allows me to invest in companies that I want to see succeed and make an impact on the world, read my investor story
Refer OnMarket
Over $290,500 in reward payments so far
Join OnMarket
Refer OnMarket
Earn 25% of our selling fee
